<DOC>
	<DOCNO>NCT02097420</DOCNO>
	<brief_summary>The purpose study provide evidence safety effectiveness study valve . The rationale offer replacement mitral valve patient anatomy small currently commercially available valve range size 16mm 37mm .</brief_summary>
	<brief_title>HALO : A Single Arm Prospective Investigation SJM™ Masters HP™ 15mm Rotatable Mechanical Heart Valve</brief_title>
	<detailed_description>The study single arm , prospective , non-randomized , multi-center clinical investigation . The objective study evaluate safety effectiveness 15mm MHV subject five year less age diseased , damage , malfunction mitral heart valve . The objective evaluated assess valve-related adverse event , subject survival , subject growth , echocardiogram assessment hemodynamic function five year follow-up visit long valve remain implanted .</detailed_description>
	<criteria>1 . Subject require mitral valve replacement . * *Subjects undergo concomitant procedure ( e.g . valve repair ) eligible study note exclusion criterion . 2 . Subject 's legally authorize representative give write consent participate clinical study . 3 . Subject willing able return data collection followup duration clinical study . 1 . Subject &gt; 5 year age . 2 . Subject contraindication anticoagulant/antiplatelet medication . 3 . Subject prosthetic valve ( ) site mitral valve prior study procedure . * *Subjects undergone previous Ross procedure pulmonary valve eligible study . 4 . Subject require concomitant replacement tricuspid , pulmonary , aortic valve . 5 . Subject active endocarditis . 6 . Subject active myocarditis . 7 . Subject acute preoperative neurological deficit return baseline stabilize ≥ 30 day prior study procedure . 8 . Subject acute cardiac adverse event return baseline stabilize ≥ 48 hour prior study procedure . 9 . Subject noncardiac illness result life expectancy &lt; 1 year . 10 . Subject know requirement additional cardiac surgery within 12 month study procedure . 11 . Subject previously enrol implant study . 12 . Subject participate another study investigational drug and/or device . 13 . Subject medical condition opinion Investigator interfere study result .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Mitral valve</keyword>
</DOC>